Is this Ironic or What?

Discussion in 'Sunovion' started by Anonymous, Feb 20, 2012 at 11:01 PM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    Dainippon wins manufacturing approval for sleep inducing therapy in Japan
    PBR Staff Writer Published 20 February 2012

    Dainippon Sumitomo Pharma has obtained manufacturing and marketing approval for Zolpidem tartrate tablets 5mg/10mg [DSP] from the Ministry of Health, Labour and Welfare in Japan.

    Zolpidem tartrate tablets 5mg/10mg [DSP] are film-coated tablets containing 5mg or 10mg of zolpidem tartrate, with a score line on one side, which are indicated for the treatment of Insomnia.

    The usual adult dose is once daily 5 to 10mg of zolpidem tartrate administered orally immediately before bedtime, the company said.

    The initial dose for elderly patients is from 5mg once daily and may be adjusted depending on age, symptoms, disease, and should not exceed 10mg once daily.


    You gotta love it. And I wonder how Eisai (who has Lunesta rights in Japan) feels about it!
     

  2. Anonymous

    Anonymous Guest

    What does ironic mean?
     
  3. Anonymous

    Anonymous Guest

    Dainippon Sumitomo Pharma announces the launch of Sleep Inducing Treatment “Zolpidem tartrate tablets 5mg/10mg [DSP]”

    Previous ArticleCanon commences sales of new FPA-3030i5+ stepper for high-volume production of green devices and MEMS

    June 26, 2012

    June 26, 2012 -- Dainippon Sumitomo Pharma Co., Ltd. (DSP) (Headquarters: Osaka, Japan; President: Masayo Tada) announces the launch of sleep inducing treatment “Zolpidem tartrate tablets 5mg/10mg [DSP]” in Japan, as of June 28, 2012.

    In the pharmaceutical business in Japan, DSP designates the Central Nervous System field as one of its focus marketing areas, and offers various treatments such as atypical antipsychotics "LONASEN(R)" and "LULLAN(R)", Parkinson's disease drug "TREREIF(R)", norepinephrine-activating neural function ameliorant "DOPS(R)", anti-epileptic drug "EXCEGRAN(R)", and serotonin-agonist antianxiety drug "SEDIEL(R)". DSP is currently engaging in activities to provide information on these products in addition to the anti-depressant "Paxil(R) CR".

    Moreover, as part of a plan to strengthen the lineup in the CNS area, DSP is handling generic drugs in this therapeutic area. In December 2011, DSP launched Donepezil hydrochloride tablets/OD tablets 3mg/5mg [DSP] in Japan. This time, adding Zolpidem tartrate tablets 5mg/10mg [DSP] to the product lineup, DSP intends to further meet the diverse needs of medical personnel in the CNS area.

    In the future, DSP will positively introduce products to contribute to the treatment of CNS disorders regardless of whether they are new or generic drugs.

    For more information, please visit http://www.ds-pharma.com/pdf_view.php?id=249